INS and Hyperglycemia: However, hyperglycemia and insulin requirements were problematic for patients in the treatment group, leading the authors to conclude that the risks for reconstructive patients outweighed the benefits.60 In contrast, systematic reviews have concluded that the benefits from dexamethasone outweigh the concerns of hyperglycemia, except for patients with brittle diabetes mellitus.